TAKE YOUR REHABILITATION TO NEW HEIGHTS
IRegained: Fast Facts
IRegained is a medical device company developing novel solutions for the physical rehabilitation needs of people with disability.
With a mission to help 100 million stroke survivors with hand function disability from brain injury, IRegained has developed the MyHand™ System – a neuroplasticity research-driven, telemedicine-powered, clinically effective and affordable hand function rehabilitation system.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Enormous Problem
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Disappointing Paradigm
Recovering hand function requires targeted neuro-rehabilitation therapy with intensity and repetition for months and potentially years (10-20 sessions per week).
Furthermore, there are very few clinically validated hand-function rehabilitation devices in the market.
Those that exist are either ineffective (ex: squeeze balls, rubber bands, etc.) because they do not leverage neuroplasticity to recover the brain’s ability to control the hand, or cost prohibitive (e.g. robotic devices >$150,000) and therefore unaffordable.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
One Outstanding Solution
IRegained has developed the MyHand™ System, a proprietary hand function rehabilitation system that aims to restore lost hand function in stroke or brain trauma survivors.
The system leverages neuroplasticity, the human brain’s ability to ‘reprogram’ its neural pathways.
Backed by 40 years of clinical and scientific research-based evidence and with guidance from accomplished rehab professionals, this system can help people with hand-function disability regain their independence.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Key Features
The MyHand System is:
Intelligent
Smart device built on proven clinical protocols for targeted hand therapy.
Connected
IoMT-based internet-connected device with built-in IRegained app store to access engaging hand-rehab games.
Neuroplastic
Intelligent algorithms developed through deep scientific research on leveraging neuroplasticity and applying it for motor control recovery.
Built for Tele-Rehab
Integral telemedicine platform for remote rehabilitation in the comfort of patient’s home – particularly critical in COVID-19 Pandemic.
Effective
Proven clinical efficacy in recovery of hand function.
Affordable
Affordable system with attractive financing and leasing options.
Ready for home use
One of the very few rehabilitation systems than can be effectively used in the comfort of home.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Why We’ll Lead
IRegained is serving a large, poorly met market that has yet to find the solution they need to live a healthier, more functional life.
We offer a compelling value proposition for customers across both B2B and B2C. There is 4-5 month pay back period and strong ROI for clinics and long term-care institutions.
Further, COVID-19 has ignited the telemedicine market, and IRegained’s MyHand™ System was designed with telemedicine in mind.
Our offering has a low risk regulatory classification (class 1 classification = faster time to market) with pending patents in US, EU, Canada, China and India (Strong IP = higher competitive barrier).
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Traction & Accomplishments
IRegained MyHand™ System has secured significant interest of purchase from leading clinics and rehabilitation centers with just the MVP version of the system. All the participants of the MyHand System study and customer validation trials are interested to purchase the system, and to-date additional over 12 clinics and 10 hospitals are interested to purchase.
Clinical studies initiated at Baycrest & McMaster University are now about to resume. Awaiting final details.
International research collaboration with:
Research at Sunnybrook Hospital is now in the final funding approval stage. IRegained is preparing documentation to secure $125,000 in funding to support product development
IRegained attained funding through MITACS to support gamification process for the MyHand™ system
IRegained has now received research grants from OCE/NSERC for CAD $75,000.
IRegained is planning to launch the second phase of early-adopter customer campaign with its IoMT connected alpha prototype under a “loan-to-own” program
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Partnerships
IRegained has established a number of key partnerships and is in the process of building a global network of strategic alliances in a number of areas including: Scientific & Clinical Collaboration, R&D, and Commercialization.
TAKE YOUR REHABILITATION TO NEW HEIGHTS
Meet The Team
Vineet Johnson, BSc.PT., PG.Dip.PT., MSc, PhD(c)
CHIEF EXECUTIVE OFFICER
Neuroscientist and Physiotherapist with more than 25 years clinical/research experience in Canada, UK and India
Samir Sahoo, B.E., MBA (Purdue University, USA)
CHIEF OPERATING OFFICER
Michael Dolinar, B.Sc. Comp Sc
CHIEF TECHNOLOGY OFFICER
Ranjit Stanley, BSc.PT. (Christian Medical College & Hospital - India)
CHIEF SCIENTIFIC OFFICER
Joel Liederman, B.Eng, MBA
DIRECTOR, CORPORATE DEVELOPMENT
Accomplished senior executive with more than 45 years of high-tech company leadership, domestic and international business development expertise, and venture capital experience in high-tech industries
The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.
You must have an account to do this!
the startups.com platform
Copyright © 2019 Startups.com. All rights reserved.
Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.